Open AccessVaccination with Fendrix of prior nonresponding patients with HIV has a high success rate
Author(s) -
Julian D Machiels,
Esmee E. Braam,
Petra van Bentum,
Michèle van Vugt,
Theodora E. M. S. de Vries-Sluijs,
Ineke W. E. M. Schouten,
Wouter F W Bierman,
Elisabeth H. Gisolf
Publication year - 2019
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0000000000002085
Subject(s) - seroconversion , medicine , vaccination , confidence interval , serology , hepatitis b virus , logistic regression , immunology , hepatitis b , human immunodeficiency virus (hiv) , virus , antibody
Patients with HIV have a poor serological conversion rate with the standard vaccination strategy against hepatitis B virus (HBV) of around 50%. Vaccination with Fendrix confers much better results in these patients. In this study, we tested the effect of revaccination with Fendrix in prior nonresponding patients with HIV and aimed to determine which factors are associated with seroconversion.